Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed11

Role Distribution

Principal Investigator11
PI Rate100%

Activity Timeline

Clinical Trials (11)

NCT07619508Completed
Tirzepatide vs Semaglutide in Individuals at Cardiovascular Risk But Without Diabetes.
ObesityOverweight
PrincipalinvestigatorStart date: 2026-02-10
NCT07417631Completed
Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data.
Type 2 Diabetes
PrincipalinvestigatorStart date: 2026-02-03
NCT07619495Completed
Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk
ObesityOverweightType 2 Diabetes Mellitus
PrincipalinvestigatorStart date: 2026-01-20
NCT07203677Completed
Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)
Atherosclerotic Cardiovascular DiseaseType2 Diabetes Mellitus
PrincipalinvestigatorStart date: 2025-09-19
NCT06914102Completed
Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data
Diabetes Mellitus, Type 2HFpEF - Heart Failure With Preserved Ejection Fraction
PrincipalinvestigatorStart date: 2025-01-14
NCT06914141Completed
Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection Fraction
Diabetes Mellitus, Type 2HFpEF - Heart Failure With Preserved Ejection Fraction
PrincipalinvestigatorStart date: 2025-01-14
NCT06914154Completed
Emulation of the SUMMIT Heart Failure Trial in Healthcare Claims Data
Diabetes Mellitus, Type 2Heart Failure With Preserved Ejection Fraction (HFPEF)
PrincipalinvestigatorStart date: 2025-01-14
NCT07088718Completed
Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data
Cardiovascular (CV) RiskMajor Adverse Cardiac EventsType 2 Diabetes
PrincipalinvestigatorStart date: 2024-10-01

Showing 10 of 11 trials

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Shirley Wang, PhD, ScM

Brigham and Women's Hospital

Very Similar
51 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2OverweightCardiovascular (CV) Risk+8 more

Worked with same sponsors:

Brigham and Women's Hospital
Collaborated on 11 trials
Similarity Score154%

David Crowley, MD

KGK Science Inc.

Related
54 trials

Shared therapeutic areas:

OverweightDiabetes Mellitus, Type 2Obesity
Similarity Score8%

Andrea Natale, MD

Texas Cardiac Arrhythmia Research Foundation

Related
18 trials

Shared therapeutic areas:

Heart FailureHFpEF - Heart Failure With Preserved Ejection FractionObesity
Similarity Score8%

David Meeker, MD

Rhythm Pharmaceuticals, Inc.

Related
19 trials

Shared therapeutic areas:

ObesityOverweight
Similarity Score5%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Obesity
Similarity Score5%

Suman Wason, MD

Lexicon Pharmaceuticals, Inc.

Related
23 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Heart Failure
Similarity Score5%

Jack A Yanovski, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related
23 trials

Shared therapeutic areas:

ObesityOverweight
Similarity Score5%

ali ismail, lecturer

Cairo University

Related
29 trials

Shared therapeutic areas:

ObesityDiabetes Mellitus, Type 2
Similarity Score5%

David s Ludwig, MD, PhD

Boston Children's Hospital

Related
17 trials

Shared therapeutic areas:

ObesityOverweight

Worked with same sponsors:

Brigham and Women's Hospital
Similarity Score5%

Samuel Klein, MD

Washington University School of Medicine

Related
30 trials

Shared therapeutic areas:

ObesityDiabetes Mellitus, Type 2
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (11)

Showing 11 of 11 trials

NCT07619508PrincipalInvestigator

Tirzepatide vs Semaglutide in Individuals at Cardiovascular Risk But Without Diabetes.

ObesityOverweight
Completed
NCT07417631PrincipalInvestigator

Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data.

Type 2 Diabetes
Completed
NCT07417618PrincipalInvestigator

INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)

ASCVDOverweightType 2 Diabetes
Completed
NCT07390110PrincipalInvestigator

Comparative Effectiveness of Oral Semaglutide vs Sitagliptin Among Individuals With Heart Failure With Preserved Ejection Fraction (STEP-HFpEF DM ORAL)

Heart FailureType 2 Diabetes
Completed
NCT07619495PrincipalInvestigator

Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk

ObesityOverweightType 2 Diabetes Mellitus
Completed
NCT07203677PrincipalInvestigator

Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)

Atherosclerotic Cardiovascular DiseaseType2 Diabetes Mellitus
Completed
NCT06914102PrincipalInvestigator

Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data

Diabetes Mellitus, Type 2HFpEF - Heart Failure With Preserved Ejection Fraction
Completed
NCT06914141PrincipalInvestigator

Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection Fraction

Diabetes Mellitus, Type 2HFpEF - Heart Failure With Preserved Ejection Fraction
Completed
NCT06914154PrincipalInvestigator

Emulation of the SUMMIT Heart Failure Trial in Healthcare Claims Data

Diabetes Mellitus, Type 2Heart Failure With Preserved Ejection Fraction (HFPEF)
Completed
NCT07088718PrincipalInvestigator

Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data

Cardiovascular (CV) RiskMajor Adverse Cardiac EventsType 2 Diabetes
Completed
NCT07096063PrincipalInvestigator

Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk

Cardiovascular (CV) RiskOverweightType 2 Diabetes
Completed

All 11 trials loaded